Twist Bioscience Q3 EPS $(1.01) Beats $(1.14) Estimate, Sales $63.74M Beat $60.71M Estimate
Portfolio Pulse from Benzinga Newsdesk
Twist Bioscience (NASDAQ:TWST) reported Q3 earnings per share (EPS) of $(1.01), beating the analyst consensus estimate of $(1.14) by 11.4%. This is a 6.48% increase over losses from the same period last year. The company also reported quarterly sales of $63.74 million, beating the analyst consensus estimate of $60.71 million by 4.99%. This is a 13.59% increase over sales from the same period last year.
August 04, 2023 | 3:09 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Twist Bioscience reported better than expected Q3 earnings and sales, which could positively impact the stock price.
Twist Bioscience reported Q3 earnings and sales that beat analyst estimates. This is generally seen as positive news and could lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100